| Name | Title | Contact Details |
|---|---|---|
Justin Dean |
Chief Information Officer | Profile |
Justin Dean |
Chief Technology Officer and Chief Information Officer | Profile |
Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders. Promentis` drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders. The Company`s lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.
New York State Pharmacist: Century Ii is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lindus Health is a next generation CRO that helps biotech and healthtech pioneers run faster, more reliable clinical trials. They provide end-to-end clinical trial services, including trial design, recruitment, and delivery, and have a unique technolog...
Hollister Stier is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Process Control Solutions is a Northborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.